Azelastine and Geodon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azelastine (azelastine hydrochloride) and Geodon (ziprasidone hydrochloride). Common drug interactions include drug ineffective among females and akathisia among males.

The phase IV clinical study analyzes what interactions people have when they take Azelastine and Geodon. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,399 Azelastine users. Check the latest studies of Azelastine.

What is Geodon?

Geodon has active ingredients of ziprasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 19,504 Geodon users. Check the latest studies of Geodon.

On Jul, 08, 2026

18 people who take Azelastine and Geodon together, and have interactions are studied.

Azelastine and Geodon drug interactions.

What are the common drug interactions of Azelastine and Geodon, by gender? *:

female:

Drug ineffective
Asthenia (weakness)
Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Sinusitis (inflammation of sinus)
Urinary tract infection
Suicidal ideation
Aphasia (damage to the parts of the brain that control language)

male:

Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Somnolence (a state of near-sleep, a strong desire for sleep)
Drug ineffective
Erythema (redness of the skin)
Hypoaesthesia (reduced sense of touch or sensation)
Malaise (a feeling of general discomfort or uneasiness)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Pain
Pain in extremity
Pathological gambling

What are the common drug interactions of Azelastine and Geodon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Drug ineffective

20-29:

Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
Blood creatinine increased

30-39:

n/a

40-49:

Chronic kidney disease

50-59:

Aphasia (damage to the parts of the brain that control language)
Confusional state

60+:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal injury (kidney injury)

What are the existing conditions these people have? *

High Blood Cholesterol: 5 people, 27.78%
Depression: 4 people, 22.22%
Stress And Anxiety: 4 people, 22.22%
Immunodeficiency Common Variable: 4 people, 22.22%
Psychotic Disorder: 3 people, 16.67%
Ill-Defined Disorder: 2 people, 11.11%
Pain: 2 people, 11.11%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 11.11%
Affective Disorder (mental disorder): 2 people, 11.11%
Nausea (feeling of having an urge to vomit): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Azelastine and Geodon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously